Keryx Biopharmaceuticals Inc. said it expected to benefit from proposed U.S. legislation that would continue a pricing system for dialysis drugs, sending its shares up the most in almost five months.
http://ift.tt/1jNkMLC
http://ift.tt/1jNkMLC
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment